Wu Y - Search Results

1

CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes.

Liu Y, Wu Y, Zhang P, Xu C, Liu Z, He C, Liu Y, Kang Z. Liu Y, et al. Among authors: wu y. Front Oncol. 2021 Mar 4;11:636870. doi: 10.3389/fonc.2021.636870. eCollection 2021. Front Oncol. 2021. PMID: 33747959 Free PMC article.

2

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer.

Wu Y, Liu Y, He A, Guan B, He S, Zhang C, Kang Z, Gong Y, Li X, Zhou L. Wu Y, et al. Front Genet. 2020 Aug 28;11:992. doi: 10.3389/fgene.2020.00992. eCollection 2020. Front Genet. 2020. PMID: 32983230 Free PMC article.

3

Identification of Germline Mutations in Upper Tract Urothelial Carcinoma With Suspected Lynch Syndrome.

Guan B, Wang J, Li X, Lin L, Fang D, Kong W, Tian C, Li J, Yang K, Han G, Wu Y, He Y, Peng Y, Yu Y, He Q, He S, Gong Y, Zhou L, Tang Q. Guan B, et al. Among authors: wu y. Front Oncol. 2022 Mar 16;12:774202. doi: 10.3389/fonc.2022.774202. eCollection 2022. Front Oncol. 2022. PMID: 35372080 Free PMC article.

4

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.

Wu Y, Zhang L, He S, Guan B, He A, Yang K, Gong Y, Li X, Zhou L. Wu Y, et al. Aging (Albany NY). 2020 Nov 18;12(22):23306-23325. doi: 10.18632/aging.104115. Epub 2020 Nov 18. Aging (Albany NY). 2020. PMID: 33221763 Free PMC article.

5

P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.

Wu Y, Peng Y, Guan B, He A, Yang K, He S, Gong Y, Li X, Zhou L. Wu Y, et al. Oncol Lett. 2021 Feb;21(2):95. doi: 10.3892/ol.2020.12356. Epub 2020 Dec 6. Oncol Lett. 2021. PMID: 33376528 Free PMC article.

6

Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer.

Zhang C, Qian J, Wu Y, Zhu Z, Yu W, Gong Y, Li X, He Z, Zhou L. Zhang C, et al. Among authors: wu y. Pathol Oncol Res. 2021 Sep 27;27:1609968. doi: 10.3389/pore.2021.1609968. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34646089 Free PMC article.

7

Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer.

Wu Y, Xu Y, He S, Li Y, Feng N, Fan J, Gong Y, Li X, Zhou L. Wu Y, et al. Heliyon. 2023 Feb 13;9(3):e13707. doi: 10.1016/j.heliyon.2023.e13707. eCollection 2023 Mar. Heliyon. 2023. PMID: 36873531 Free PMC article.

8

MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.

He A, He S, Huang C, Chen Z, Wu Y, Gong Y, Li X, Zhou L. He A, et al. Among authors: wu y. Aging (Albany NY). 2020 Jan 24;12(2):1465-1487. doi: 10.18632/aging.102694. Epub 2020 Jan 24. Aging (Albany NY). 2020. PMID: 31978894 Free PMC article.

9

Natural history of Von Hippel-Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study.

Wang J, Zhang L, Qiu J, Li Z, Wu Y, Zhang C, Yao L, Gong K, Li X, Zhou L. Wang J, et al. Among authors: wu y. J Cancer Res Clin Oncol. 2022 Oct;148(10):2631-2641. doi: 10.1007/s00432-021-03806-0. Epub 2021 Oct 28. J Cancer Res Clin Oncol. 2022. PMID: 34709473

10

MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.

Wu Y, Zhang C, Peng D, He S, Huang C, Qian J, Zhu W, Feng N, Gong Y, Li X, Zhou L. Wu Y, et al. Hum Cell. 2022 Mar;35(2):542-556. doi: 10.1007/s13577-021-00661-6. Epub 2022 Feb 7. Hum Cell. 2022. PMID: 35129808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86,548 results

Search Page

Filters